Tuberculosis cutánea y pulmonar en paciente inmunocompetente
Iglesias Siguenza, A; Carpio Segura, C; Vidal, JL; Álvarez-Sala Walther, R.
Rev. patol. respir
; 18(3): 118-120, jul.-sept. 2015. ilus
Artículo en Español | IBECS (España) | ID: ibc-144250
Documentos relacionados
Healing activities construct the objects of therapy: Medicine's way of seeking truth, organizing forms of reality, regulating patients' bodies, illness and culture?
Co-existence of atypical tuberculid with lupus vulgaris.
Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
T3 translational science in gastroenterology: getting to best outcomes.
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.
It's time for scientists to shout about RNA therapies.
Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance.
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions.
CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
FedEx for your cells: this biological delivery service could treat disease.